Saiseikai Central Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00369148
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Department of Neurology, Saiseikai Central Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

mitiglinide (Glufast) (1 trial)

nateglinide (starlix) (1 trial)

Drugs in Phase 3 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

cilostazol (pletal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebrovascular Disorders (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4